Recent evidence shows that kratom is addictive and fatal overdoses are possible. When taken in high doses, kratom can produce opioid-like effects, allowing the user to experience euphoria as well as a sedative effect. According to the FDA, “kratom, which affects the same opioid brain receptors as morphine, appears to have properties that expose users to the risks of addiction, abuse, and dependence.” Like opioids, those who use kratom regularly can become dependent and/or experience withdrawals.

We treat kratom use disorder like we do opioid use disorder with medications like buprenorphine and naltrexone along with targeted psychosocial services.  

Researchers at Ideal Option presented the largest case series to date exploring long-term buprenorphine/naloxone treatment for kratom use disorder (KUD). After 12 weeks of treatment, 82% of participants had negative test results for mitragynine (kratom). To read the full article published in the Substance Abuse journal, click here: https://bit.ly/3GB6f5z.